UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
---------------
FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 20, 2015

Kraig Biocraft Laboratories, Inc.

---------------
(Exact name of Registrant as specified in charter)
 
Wyoming
 
333-146316
 
83-0459707
(State of Incorporation)
 
(Commission File No.) 
 
(IRS Employer
Identification Number)
 
 
120 N. Washington Square, Suite 805, Lansing, Michigan
 
48933
(Address of principal executive offices)
 
(Zip Code)
 

Registrant's telephone number, including area code:  (517) 336-0807
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o Written communications pursuant to Rule 425 under the Securities Act (17CFR230.425)
o Soliciting material pursuant to Rule14a-12 under the Exchange Act (17CFR240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR240.13e-4(c))
 
 



 
 
 
 
 
 
Item 5.02                      Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 20, 2015, the board of directors of Kraig Biocraft Laboratories, Inc. (the “Company”) appointed Mr. Jonathan R. Rice as its Chief Operating Officer. Set forth below is a brief biography of Mr. Rice:

Jonathan R. Rice, age 35, had worked at Ultra Electronics, Adaptive Materials Inc., a Michigan company (“UEA”) since 2002. At UEA, he worked as the Director of Advanced Technologies since 2002, where he was responsible for new products development and commercialization. He was also the Corporate Facility Security Officer for UEA since 2006, where Mr. Rice ensured UEA’s compliance with federal regulations under the National Industrial Security Program Operating Manual and completed its annual security audit. During 2004 through 2007 while working as an Engineering Manager at UEA, Mr. Rice, among other things, led the design and development of multiple fuel cell and power management systems, established a team to identify and eliminate production and performance limitation, authored technical progress and final reports for customers and provided training to military personnel on use of fuel cell systems. From 2002 through 2005, Mr. Rice had also served as UEA’s Production Manager in charge of developing manufacturing process and techniques and sourcing the production equipment for UEA’s products. Mr. Rice graduated from Michigan Technological University in 2002 with a degree of Bachelors of Science Chemical Engineering. Mr. Rice is currently studying for his Masters of Business Administration at Michigan State University and expects to graduate in 2016.
 
In connection with his appointment as the Company’s Chief Operating Officer, the Company entered into an at-will employment agreement with Mr. Rice (the “Employment Agreement”) on January 20, 2015. The Employment Agreement has a term of one year and can be terminated by either the Company or Mr. Rice at any time. Under the Employment Agreement, Mr. Rice is entitled to an annual cash compensation of $120,000, which includes salary, health insurance, 401K retirement plan contributions, etc. The Company also agreed to reimburse Mr. Rice for his past educational expenses of approximately $11,000. In addition, Mr. Rice will be issued a three-year warrant to purchase 2,000,000 shares of common stock of the Company at an exercise price of $0.001 per share pursuant to the Employment Agreement.

The foregoing description of the Employment Agreement is qualified in its entirety by the text of the Employment Agreement which is annexed hereto as Exhibit 10.1.

Item 7.01                      Regulation FD Disclosure.

On January 21, 2015, the Company issued a press release regarding the appointment of Mr. Jonathan R. Rice as its Chief Operating Officer. A copy of the press release is filed hereof as Exhibit 99.1.

Item 9.01                      Financial Statements and Exhibits .

(d)      The following exhibits are filed with this report:
 
Exhibit No.
 
Description
 
 
Employment Agreement dated January 19, 2015 by and between the Company and Jon Rice.

 
Press release, dated January 21, 2015.

 

 
2

 

 
SIGNATURES
 
             Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 

 
Kraig Biocraft Laboratories, Inc.
 
       
Date: January 21, 2015
By:
/s/  Kim Thompson  
   
Name: Kim Thompson
 
   
Title: CEO
 
       
Exhibit 10.1
 
At-Will Employment
 
In consideration of the mutual covenants set forth below, and for other valuable consideration, the sufficiency and adequacy of which is hereby acknowledged, Kraig Biocraft Laboratories, Inc., (hereafter Employer or Company or Kraig) agrees to hire Jon Rice, (hereafter Mr. Rice or Employee) on an at-will basis and Employee agrees to work for Employer as set forth in this Agreement.
 
The Company and Employee each desires that Employee furnish services to the Company on the terms and conditions hereinafter set forth. The parties enter into this agreement setting forth the terms and conditions of the employment of the Employee with the Company.
 
        NOW, THEREFORE, in consideration of the foregoing and of the mutual promises and undertakings contained in this Employment Contract, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, and intending to be legally bound hereby, the parties hereto agree as follows:
 
Employment. The Company hereby agrees to employ the Employee, and the Employee hereby accepts such employment, on the terms and conditions hereinafter set forth.
 
Term. The term of Employee's employment under this At Will Employment Agreement shall be for a period of one (1) year, commencing on January 19, 2015 and ending on January 18, 2016, unless further extended by mutual written or sooner terminated as hereinafter provided. This is an AT WILL agreement which may be terminated by either party at any time. Any extension or modification of this agreement will be in the form of an employment contract, signed by the Employee and the CEO and will contain the words “Employment Agreement in its title.  No such modification or extension shall be valid unless it is approved by the Company’s board of Directors)
 
This Agreement is dated January 19, 2015
 
1.           DESCRIPTION OF DUTIES
 
A.           Name of Position
The Mr. Rice shall be employed in the capacity of Chief Operations Officer (COO) and shall report directly to the CEO and carry out the duties and tasks assigned to him by the CEO.
 
C.           Duty of Loyalty and Best Effort
Employee shall devote all of his/her working time, attention, knowledge, and skills to Employer's business interests and shall do so in good faith, with best efforts, and to the reasonable satisfaction of the Employer.  Employee understands that they shall only be entitled to the compensation as set forth in this Agreement.
 
D.           Place and Hours of Employment
Employee understands that that their duties shall be primarily rendered at Employer’s business premises or at such other places as the Employer shall in good faith require.  The position is full time.
 
 
 
 

 
 
E.  
Compensation
 
Signing Bonus : As a signing bonus for coming to work for Employer and for signing this agreement, Mr. Rice will receive a warrant on 2,000,000 shares of the Company’s common stock at a strike price of $0.001 with a cashless exercise provision.  The warrant vests immediately upon the signing of this agreement. The warrant will be exercisable on February 2, 2016 and on any day thereafter falling on or before the expiration of the warrant.  The warrant will expire on January 19, 2018.
 
Annual Compensation : The cash portion is an annual allocation of $120,000 to be divided between salary, health insurance, tuition expense for the ongoing Executive MBA program, and possible: 1) 401k contributions, 2) HSA contributions and 3) life insurance premiums.  It is the intention of the Company that the $120,000 is inclusive of all payroll and compensation costs other than the employer portion of payroll withholdings.  The precise allocation of the $120,000 among these categories will be the subject of further discussions and the input of Mr. Rice.
 
In addition the Company will pay the monthly costs for mobile service for Mr. Rice’s mobile phone while he is employed by the Company.
 
The Company has agreed that it will implement a 401k for Mr. Rice’s benefit if such can be implemented with reasonable cost and convenience.
 
In addition, Mr. Rice has disclosed that he might incur costs for past educational expenses.  In that event, the Company has agreed that it will cover cost (anticipated to be approximately $11,000) and that this payment for past educational expenses will not be a deduction from the $120,000 figure referenced above.
 
2.           TERMINATION
 
“At Will” Employment
Employee’s employment with Employer is “at will.”  “At will” is defined as allowing either Employee or Employer to terminate the Agreement at any time, for any reason permitted by law, with or without cause and with or without notice.
 
 
3.  
COVENANTS
 
A.
Non-Disclosure of Trade Secrets, Customer Lists and Other Proprietary Information
Employee agrees not to use, disclose or communicate, in any manner, proprietary information about Employer, its operations, product development, scientific research, business plans, production methodologies, clientele, or any other proprietary information, that relate to the business of Employer.  This includes, but is not limited to, the names of Employer’s customers, its marketing strategies, operations, research and development or any other information of any kind which would be deemed confidential or proprietary information of Employer including but not limited to: Business plans, areas of research and research methodologies, the identities of Employers production, commercialization and research partners.
 
Employee acknowledges that the above information is material and confidential and that it affects the profitability of Employer.  Employee understands and that any breach of this provision, or of any other Confidentiality and Non-Disclosure Agreement, is a material breach of this Agreement.
 
To the extent Employee feels that they need to disclose confidential information; they may do so only after being authorized to so do in writing by Employer.
 
 
 
 

 
 
B.              
Confidential Information .
Employee agrees that, during the term of this Agreement and at all times thereafter , Employee will treat as confidential and maintain in confidence all information relating to the business of Kraig, including without limitation the areas of research and investigation that Kraig is or has been pursuing, Kraig's business plans, the identity of the customers, suppliers, and joint researchers of Kraig, Kraig's arrangements with such parties, and technical data relating to Kraig's products, services and research, including without imitation, genetic sequences and methods for creating transgenic silkworms, testing data relating to Kraig products, the location of Kraig’s testing and production operations, the identity of parties which Kraig is negotiating with, trade secrets of Kraig, and in addition, communications with or from Kraig.  All such information as described above in this paragraph is “Confidential Information” and is referred to as such in this document.  All documents or information that an executive officer of Kraig has identified, either verbally or in writing, as confidential, shall also be deemed confidential for purposes of this paragraph.  In addition, Employee agrees that, without the prior written approval of Kraig, Employee will not disclose any such information at any time to any person, corporation, or other entity except authorized personnel of Kraig.  Upon the termination of this Agreement for any reason, Employee will not take or retain any records, files or other documents, or copies thereof, relating in any way to the business operations of Kraig or any subsidiary of Kraig.
 
C.             Non Disparagement.   Employee agrees that during the term of this agreement and for a period of three years following the termination of this agreement they will not intentionally make any disparaging, libelous, slanderous or defamatory statements directly or indirectly in any form against Employer or any of Employer’s executives or other employees.
 
D.           Adherence to Employer's Policies, Procedures, Rules and Regulations
Employee agrees to adhere by all of the policies, procedures, rules and regulations set forth by the Employer.  To the extent that Employer’s policies, procedures, rules and regulations conflict with the terms of this Agreement, the specific terms of this Agreement will control.
 
E.           Covenant to Notify Management of Unlawful Acts or Practices
Employee agrees to abide by the legal and ethics policies of Employer as well as Employer’s other rules, regulations, policies and procedures.  Employer intends to comply in full with all governmental laws and regulations as well as any ethics code applicable to their profession.  In the event that Employee is aware of Employer, or any of its officers, agents or employees, violating any such laws ethics codes, rules, regulations, policies or procedures, Employee agrees to bring forth all such actual and suspected violations to the attention of Employer immediately so that the matter may be properly investigated and appropriate action taken.
 
 
 
 

 
 
4.  
PROPERTY RIGHTS
 
A.           New Customers or Clientele Generated While at Work
Employee agrees that any customers or clientele generated by Employee pursuant to employment with Employer are the customers and clientele of the Employer and subject to the non-disclosure and non-solicitation covenants set forth above.
 
B.           Records and Accounts
Employee agrees that all those records and accounts maintained during the course of employment are the property of Employer, shall remain current and be maintained at Employer’s place of business.
 
C.           Return Upon Termination
Employee agrees that upon termination they will return to Employer all of Employer’s property, including, but not limited to, intellectual property, trade secret information, customer lists, operation manuals, employee handbook, computers, computer files, records and accounts, materials subject to copyright, trademark, or patent protection, customer and Employer information, credit cards, business documents, reports, automobiles, keys, passes, and security devices.
 
D.           Copyrights, Inventions and Patents
Employee understands that any copyrights, inventions or patents created or obtained, in part or whole, by Employee during the course of this Agreement are to be considered “works for hire” and the property of Employer.  Employee assigns to Employer all rights and interest in any copyright, invention, patents or other property related to the business of the Employer.
 
5.           Entire Agreement
 
This Agreement, along with the “At Will: Policy Statement,” which Employee has signed, represents the complete and exclusive statement of the employment arrangements between the Employer and Employee.  No other agreements, covenants, representations or warranties, express or implied, oral or written, have been made by the parties concerning their employment arrangement agreement.
 
6.           The Effect of Prior Agreements or Understandings
 
This Agreement supersedes any and all prior Agreements or understandings between the parties, including letters of intent or understanding, except for those documents specifically referred to within this Agreement.
 
7.           Modifications
 
Employee and Employer agree that this writing, along with the “At Will: Policy Statement” which Employee has signed, constitutes the entirety of the Employment contract between the parties.  Any modifications to this Agreement may only be done in writing and must be signed by the CEO of Employer and be approved by the board of directors of Employer.
 
8.           Severability of Agreement
 
To the extent that any provision hereof is deemed unenforceable, all remaining provisions of this Agreement shall not be affected thereby and shall remain in full force and effect.
 
 
 
 

 
 
9.           Waiver of Breach
 
The waiver by Employer of a breach of any provision of this Agreement by Employee shall not operate as a waiver of any subsequent breach by the Employee.  No waiver shall be valid unless placed in writing and signed by [an officer] of Employer.
 
10.           Ambiguities Related to Drafting
 
Employer and Employee agree that any ambiguity created by this document will not be construed against the drafter of same.
 
 
 
 
 

 
 
IN WITNESS WHEREOF, the parties have executed this Agreement effective the date first stated above.
 
  Kraig Biocraft Laboratories, Inc.  
       
 
By:
/s/ Kim Thompson  
    Kim Thompson  
    CEO  
       
 
     
       
 
By:
/s/ Jon Rice  
       
       
       
 
 
 
 
 
 
 
 
 

Exhibit 99.1
 
KRAIG BIOCRAFT LABORATORIES ANNOUNCES NEW CHIEF OPERATIONS OFFICER

Kraig Labs strengthens management team, appointing new Chief Operations Officer with strong product development and commercialization experience
 
LANSING, Mich., –January 21, 2015 - Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of advanced spider silk based fibers, announces Jon Rice as the new Chief Operations Officer effective immediately.    Jon joins Kraig from Ultra Electronics (AMI) where he was responsible for all new product development and commercialization.  While at Ultra, Jon lead the development of advanced technologies for the US and global defense markets. In his new role he will provide direction for the commercialization of Kraig labs technologies including MonsterSilk TM .

“Kraig Labs’ spider silk technology is the perfect fit for my passion and background in transitioning powerful, disruptive technologies.  Spider Silk is a product with tremendous potential and I’m honored to join a team so dedicated to seeing that vision realized.  The opportunity to be a part of the commercialization of this technology was an opportunity I could not pass up,” said Rice.

As COO Jon will be reporting directly to the Company CEO, Kim Thompson.  “We are excited that the Company has reached the point in its growth that it can bring in someone of Jon’s caliber.  He brings a proven track record of successfully transitioning products from development through to viable commercial products.  Jon will play an instrumental role in scaling up our production capacity and leading the growth of Kraig Labs.  We recruited Jon after an extensive search for a candidate we believed could make a real difference in our efforts to bring our products to market.  As part of our search we reviewed more than 1200 resumes from candidates coming out of the nation’s top MBA schools.  Jon was chosen because of his stellar track record, his experience in product development and commercialization, and his keen intellect and business drive.  His unique blend of business and technical acumen make him a great addition to our team,” Thompson concluded.

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. ( www.KraigLabs.com ), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
 
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
ir@KraigLabs.com